Hsu, Hung-Chih
Huang, Kuo-Cheng
Chen, Wei-Shone
Jiang, Jeng-Kai
Yang, Shung-Haur
Wang, Huann-Sheng
Chang, Shih-Ching
Lan, Yuan-Tzu
Lin, Chun-Chi
Lin, Hung-Hsin
Huang, Sheng-Chieh
Cheng, Hou-Hsuan
Yang, Tsai-Sheng
Chen, Chien-Chih
Chao, Yee
Teng, Hao-Wei
Funding for this research was provided by:
Bayer
Taiwan Clinical Oncology Research Foundation
Taipei Veterans General Hospital (110 DHA0100397, V110C-189, V109C-151)
Ministry of Science and Technology, Taiwan (109-2314-B-075 -081 -MY3)
Article History
Received: 16 March 2021
Accepted: 19 July 2021
First Online: 28 July 2021
Competing interests
: Hao-Wei Teng, Hung-Chih Hsu, Kuo-Cheng Huang received a research grant in this PI initiated clinical investigation trial from Bayer Taiwan Co., Ltd (Bayer was not involved in the study design, data interpretation, and manuscript preparation and review.) Wei-Shone Chen, Jeng-Kai Jiang, Shung-Haur Yang, Huann-Sheng Wang, Shih-Ching Chang, Yuan-Tzu Lan, Chun-Chi Lin, Hung-Hsin Lin, Sheng-Chieh Huang, Hou-Hsuan Cheng, Tsai-Sheng Yang, Chien-Chih Chen, Yee Chao has no actual or potential competing interests.